Alternative dosing regimens of GLP-1 receptor agonists may reduce costs and maintain weight loss efficacy

Anıl Cengiz, Calvin C. Wu, Sean D. Lawley
doi: https://doi.org/10.1101/2024.11.27.24318093

Article Information

doi 
https://doi.org/10.1101/2024.11.27.24318093
History 
  • December 1, 2024.
Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.

Author Information

  1. Anıl Cengiz*,
  2. Calvin C. Wu, M.D.† and
  3. Sean D. Lawley, Ph.D.‡,#
  1. ∗Department of Mathematics, University of Utah, Salt Lake City, UT 84112 USA
  2. †Tono Health, 90 Furman St. N801, Brooklyn, NY 11201, United States
  3. ‡Department of Mathematics, University of Utah, Salt Lake City, UT 84112 USA
  1. ↵#lawley{at}math.utah.edu
Back to top
Posted December 01, 2024.
Download PDF

Supplementary Material

Data/Code
Email
Alternative dosing regimens of GLP-1 receptor agonists may reduce costs and maintain weight loss efficacy
Anıl Cengiz, Calvin C. Wu, Sean D. Lawley
medRxiv 2024.11.27.24318093; doi: https://doi.org/10.1101/2024.11.27.24318093
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area